virus
rapidli
acquir
de
novo
mutat
replic
within
infect
host
andino
domingo
small
fraction
variant
transmit
host
eventu
fix
global
scale
within
host
mutat
impact
viral
replic
immunogen
affect
whether
increas
frequenc
larger
scale
space
time
transmiss
bottleneck
varbl
et
al
poon
et
al
host
heterogen
also
shape
viral
genet
divers
select
pressur
variou
scale
reflect
complex
molecular
immunolog
epidemiolog
constraint
grenfel
et
al
pybu
rambaut
luksza
neher
et
al
form
basi
recent
effort
forecast
influenza
evolut
luksza
neher
et
al
neher
et
al
et
al
influenza
rapid
global
evolut
subject
intens
studi
ghedin
et
al
rambaut
et
al
origin
variat
within
singl
infect
host
still
poorli
understood
recent
deepsequenc
studi
human
clinic
sampl
suggest
influenza
accumul
rel
limit
genet
divers
within
host
acut
infect
dini
et
al
poon
et
al
sobel
leonard
et
al
debbink
et
al
line
earlier
studi
dog
hors
murcia
et
al
hoelzer
et
al
withinhost
mutat
may
confer
novel
antigen
properti
dini
et
al
lack
clear
function
interpret
altogeth
remain
unclear
influenza
withinhost
divers
transform
global
evolut
influenza
infect
usual
last
less
week
provid
limit
opportun
longitudin
studi
among
immunocompromis
patient
infect
last
week
month
nichol
et
al
memoli
et
al
make
possibl
examin
longerterm
withinhost
evolutionari
dynam
rocha
et
al
mcminn
et
al
roger
et
al
use
deepsequenc
character
evolutionari
dynam
influenza
within
immunocompromis
host
identifi
small
set
mutat
aris
repeatedli
within
individu
patient
across
multipl
patient
studi
global
scale
reveal
surpris
similar
evolutionari
dynam
across
multipl
spatiotempor
scale
deepsequenc
viral
sampl
collect
longitudin
four
immunocompromis
patient
longterm
influenza
infect
season
figur
patient
develop
influenza
infect
month
receiv
hematopoiet
cell
transplant
immun
cell
count
still
low
nasal
wash
sampl
collect
approxim
everi
week
patient
treat
neuraminidas
inhibitor
oseltamivir
least
durat
infect
campbel
et
al
figur
figur
supplement
sequenc
full
viral
genom
high
coverag
directli
patient
nasal
wash
sampl
use
influenzaspecif
revers
transcript
pcr
hoffmann
et
al
enrich
viral
genet
materi
figur
supplement
limit
impact
librari
prepar
sequenc
error
estim
variant
frequenc
mccrone
laur
prepar
sequenc
librari
duplic
sampl
begin
separ
reversetranscript
reaction
exclud
downstream
analys
eight
lowqual
sampl
sequenc
coverag
low
variant
frequenc
differ
greatli
replic
figur
supplement
across
influenza
genom
de
novo
mutat
aris
commonli
surfac
protein
hemagglutinin
ha
neuraminidas
na
figur
undergo
rapid
global
evolut
bhatt
et
al
mutat
fluctuat
frequenc
rare
fix
show
complex
evolutionari
dynam
emerg
within
singl
infect
individu
figur
figur
supplement
focus
withinhost
mutat
reach
frequenc
least
two
independ
sequenc
replic
patient
sampl
mani
nonsynonym
mutat
occur
site
affect
antigen
ha
koel
et
al
antivir
sensit
na
baz
et
al
van
der
vri
et
al
figur
supplement
na
particular
observ
emerg
persist
mutat
known
associ
oseltamivir
resist
baz
et
al
van
der
vri
et
al
phenomenon
strong
clinic
import
renaud
et
al
figur
supplement
sever
case
mutat
aris
independ
reach
high
frequenc
multipl
patient
figur
identifi
nine
site
influenza
genom
parallel
mutat
aros
two
patient
studi
five
ha
three
na
one
nonstructur
ns
segment
figur
figur
supplement
ha
p
na
p
permut
test
subsequ
analys
focus
primarili
ha
promin
role
antigen
evolut
koel
et
al
although
ha
mutat
aris
multipl
patient
found
evolutionari
outcom
sometim
diverg
instanc
aris
patient
w
z
fix
patient
z
three
patient
reach
detect
frequenc
fix
patient
x
figur
suspect
complex
dynam
withinhost
mutat
might
aris
competit
among
mutant
lineag
influenza
genom
consist
eight
linear
segment
freeli
reassort
one
anoth
recombin
boni
et
al
mean
segment
evolv
clonal
absenc
homolog
recombin
lineag
carri
benefici
mutat
rise
fall
frequenc
compet
one
anoth
make
harder
one
variant
fix
phenomenon
known
clonal
interfer
character
extens
experiment
evolut
hegr
et
al
kao
sherlock
lang
et
al
neher
affect
influenza
global
evolut
strelkowa
examin
clonal
dynam
within
individu
patient
analyz
pattern
linkag
among
withinhost
mutat
identifi
read
pair
span
multipl
variabl
site
infer
linkag
summar
relationship
haplotyp
instanc
repres
ancestr
residu
four
variabl
site
repres
doublemut
first
two
site
figur
sever
instanc
mutat
aris
parallel
distinct
genet
background
within
observ
mutat
aris
parallel
multipl
patient
studi
patient
x
lineag
carri
initi
compet
doublemut
carri
mutat
eventu
fix
figur
mutat
also
aris
multipl
time
parallel
patient
w
ancestr
haplotyp
form
singlemut
lineag
singlemut
lineag
form
doublemut
doublemut
form
triplemut
lineag
figur
recurr
mutat
also
contribut
larg
number
clonal
lineag
present
sever
week
patient
w
infect
observ
least
five
distinct
ha
lineag
frequenc
least
lineag
differ
one
three
nonsynonym
mutat
figur
eventu
lineag
carri
outcompet
lineag
carri
analysi
show
larg
clonal
evolv
influenza
popul
within
host
small
set
benefici
mutat
repeatedli
aris
compet
one
anoth
variou
combin
although
mani
benefici
mutat
select
parallel
multipl
patient
unpredict
clonal
competit
determin
mutat
eventu
fix
compar
viral
mutat
aros
within
patient
global
scale
strikingli
mani
ha
mutat
aris
parallel
multipl
patient
studi
also
reach
high
global
frequenc
may
reflect
concord
antigen
select
withinhost
global
scale
identifi
variant
reach
frequenc
least
given
year
gisaid
databas
global
influenza
sequenc
bogner
et
al
compar
variant
identifi
patient
studi
ha
site
vari
within
host
also
vari
global
influenza
popul
compar
quarter
site
influenza
gene
figur
test
whether
overlap
site
variat
within
patient
global
greater
expect
chanc
ha
na
rest
viral
genom
combin
calcul
expect
overlap
observ
number
withinhost
global
variant
drawn
random
gene
figur
supplement
site
expect
toler
mutat
also
perform
simul
consid
site
variat
human
influenza
global
instanc
ha
codon
site
show
variat
within
gisaid
databas
found
signific
parallel
ha
p
na
rest
genom
p
consid
site
global
variat
parallel
ha
evolut
remain
statist
signific
threshold
assum
less
ha
codon
site
toler
variat
parallel
especi
strike
site
ha
mutat
found
multipl
patient
studi
particular
four
five
site
recurr
withinhost
mutat
ha
also
site
global
influenza
variat
figur
figur
data
mutat
aris
multipl
patient
fix
global
decad
patient
infect
figur
mutat
also
reach
high
global
frequenc
site
although
variant
spread
global
differ
variant
aris
within
patient
howev
concord
incomplet
mutat
reach
frequenc
three
patient
rare
nonexist
influenza
global
figur
suggest
mutat
may
withinhost
benefit
reflect
global
evolut
overal
across
hemagglutinin
withinhost
variant
tend
aris
site
vari
global
scale
remark
influenza
evolut
show
extens
parallel
dispar
spatiotempor
scale
despit
heterogen
host
immun
viral
genet
background
sever
durat
infect
particular
immunocompromis
patient
studi
complex
underli
condit
divers
immun
histori
notabl
four
ha
site
display
parallel
withinhost
global
evolut
studi
also
gave
rise
mutat
anoth
studi
use
sanger
sequenc
analyz
laboratorypassag
influenza
isol
longitudin
immunocompromis
child
baz
et
al
anoth
previou
studi
use
hemagglutin
inhibit
assay
show
antigen
drift
influenza
within
immunocompromis
patient
resembl
global
antigen
chang
mcminn
et
al
similar
support
find
influenza
evolut
show
parallel
across
divers
patient
parallel
evolut
observ
influenza
withinhost
global
scale
contrast
hiv
similar
mutat
aris
within
host
share
hla
type
tend
revert
upon
transmiss
recipi
differ
hla
type
lesli
et
al
herbeck
et
al
lemey
et
al
zanini
et
al
part
differ
may
immun
epitop
influenza
broadli
similar
among
individu
except
li
et
al
linderman
et
al
wherea
target
antihiv
immun
vari
wide
due
patientspecif
factor
like
hla
type
suggest
parallel
ha
evolut
may
emerg
confluenc
sever
evolutionari
condit
et
al
first
select
act
concordantli
across
environ
favor
common
set
benefici
mutat
second
constrain
evolutionari
landscap
set
benefici
mutat
rel
small
final
given
suffici
larg
popul
size
high
mutat
rate
time
benefici
mutat
emerg
select
detect
frequenc
observ
similar
mutat
aris
repeatedli
within
singl
patient
within
multipl
differ
patient
global
scale
suggest
least
condit
may
hold
true
parallel
extens
evolut
observ
longterm
influenza
infect
contrast
limit
withinhost
variat
found
prior
studi
sampl
acut
infect
immunocompet
host
murcia
et
al
hoelzer
et
al
dini
et
al
debbink
et
al
sobel
leonard
et
al
poon
et
al
instanc
one
recent
studi
deepsequenc
ha
sever
hundr
patient
found
small
number
antigen
variant
mostli
low
frequenc
dini
et
al
studi
suggest
influenza
may
experi
mani
select
pressur
within
acut
infect
global
even
short
durat
infect
make
difficult
select
mutat
reach
frequenc
detect
current
method
suggest
withinhost
viral
divers
may
act
noisi
earli
measur
global
viral
evolut
shape
immunolog
evolutionari
constraint
highthroughput
sequenc
continu
improv
detail
character
withinhost
variat
increasingli
valuabl
understand
molecular
immunolog
epidemiolog
forc
interact
shape
viral
evolut
femal
age
group
develop
upper
respiratori
symptom
earli
day
receiv
nonmyeloabl
hct
hodgkin
diseas
day
follow
engraft
patient
nasal
wash
sampl
repeatedli
test
posit
influenza
next
day
patient
die
pulmonari
failur
diffus
alveolar
damag
found
autopsi
patient
receiv
day
cours
oseltamivir
mg
po
bid
approxim
day
infect
treat
continu
oseltamivir
last
day
life
first
mg
po
bid
increas
mg
po
bid
patient
coinfect
coronaviru
durat
influenza
infect
also
test
posit
human
metapneumoviru
last
day
life
male
age
group
develop
upper
respiratori
symptom
earli
day
receiv
nonmyeloabl
hct
hodgkin
diseas
patient
nasal
wash
sampl
repeatedli
test
posit
influenza
next
day
patient
chose
discontinu
studi
particip
patient
treat
two
cours
oseltamivir
day
cours
mg
po
bid
follow
first
posit
nasal
wash
day
cours
mg
po
bid
approxim
four
week
infect
patient
also
test
posit
cytomegaloviru
cmv
aspergillu
earli
influenza
infect
male
age
group
develop
upper
respiratori
symptom
spring
day
receiv
nonmyeloabl
hct
acut
myeloid
leukemia
aml
day
engraft
patient
nasal
wash
sampl
repeatedli
test
posit
influenza
next
day
patient
began
test
neg
patient
treat
three
cours
oseltamivir
day
cours
follow
first
posit
nasal
wash
day
cours
begin
approxim
two
week
infect
second
day
cours
start
approxim
seven
week
infect
mg
po
bid
patient
also
intermitt
test
posit
cmv
coronaviru
influenza
infect
male
age
group
develop
upper
respiratori
symptom
earli
day
receiv
nonmyeloabl
hct
aml
day
engraft
nasal
wash
sampl
repeatedli
test
posit
influenza
next
day
monitor
ceas
due
sever
ill
patient
die
day
last
influenzaposit
sampl
relaps
aml
patient
treat
two
cours
oseltamivir
day
cours
mg
po
bid
follow
first
fluposit
nasal
wash
day
cours
start
approxim
two
week
infect
began
mg
po
qd
increas
mg
po
bid
patient
also
receiv
g
ivig
day
flu
infect
patient
intermitt
test
posit
respiratori
syncyti
viru
period
also
experienc
epsteinbarr
viremia
deepsequ
viral
popul
extract
bulk
rna
nasal
wash
sampl
use
qiaamp
viral
rna
mini
kit
qiagen
accord
manufactur
instruct
possibl
extract
rna
sampl
maximum
volum
recommend
use
qiaamp
kit
captur
much
viral
divers
possibl
amplifi
influenza
genom
modifi
primer
design
hoffmann
et
al
fulllength
amplif
influenza
genom
figur
data
perform
revers
transcript
use
superscript
iii
firststrand
reaction
mix
thermo
fisher
equimolar
mix
primer
bind
conserv
region
present
influenza
gene
segment
rna
eluent
ad
anneal
buffer
um
primer
mix
incub
degre
c
min
ad
firststrand
reaction
mix
superscript
iiirnaseout
enzym
mix
ice
total
reaction
volum
incub
degre
c
min
initi
incub
design
help
bind
short
primer
degre
c
min
degre
c
min
use
entir
volum
reversetranscript
reaction
templat
pcr
reaction
use
kod
hotstart
reaction
mix
emp
millipor
cocktail
describ
figur
data
total
concentr
nm
perform
cycl
pcr
amplif
anneal
temperatur
degre
c
extens
time
min
purifi
pcr
product
use
ampur
bead
beckman
coulter
prepar
librari
illumina
sequenc
use
nextera
xt
illumina
sequenc
librari
nextseq
platform
illumina
bp
pairedend
read
perform
librari
prepar
sequenc
duplic
start
independ
reversetranscript
reaction
first
use
langmead
salzberg
filter
read
map
human
genom
remain
read
avail
sra
bioproject
use
cutadapt
martin
trim
adapt
sequenc
remain
read
remov
base
end
read
qscore
filter
read
whose
remain
length
shorter
base
local
align
trim
read
genom
genbank
access
use
langmead
salzberg
talli
count
base
genom
posit
use
custom
script
discard
read
map
score
well
base
qscore
calcul
averag
sequenc
coverag
bp
bin
along
viral
genom
prepar
sequenc
librari
use
nextera
tagment
expect
coverag
low
two
end
eight
viral
gene
segment
correspond
bin
discard
sampl
bin
averag
coverag
figur
supplement
also
identifi
site
nonconsensu
base
reach
frequenc
least
sequenc
replic
compar
variant
frequenc
replic
discard
sampl
averag
differ
variant
frequenc
two
replic
exceed
figur
supplement
total
exclud
eight
sampl
downstream
analys
sampl
shown
figur
highqual
sampl
number
ha
codon
accord
number
system
ha
number
scheme
assign
codon
full
ha
gene
begin
matur
ha
protein
codon
gene
number
sequenti
begin
one
ntermin
methionin
gene
bp
infram
bp
outoffram
overlap
nep
gene
bp
infram
bp
outoffram
overlap
annot
variant
separ
gene
occur
region
overlap
patient
studi
determin
viral
consensu
sequenc
first
sequenc
time
point
also
download
set
sequenc
global
initi
share
influenza
data
gisaid
epiflu
databas
bogner
et
al
correspond
fulllength
ha
code
region
human
influenza
isol
collect
usa
januari
decemb
gisaid
acknowledg
tabl
provid
supplementari
file
analyz
sequenc
passag
annot
unpassag
origin
indic
strain
sequenc
directli
clinic
isol
leav
uniqu
sequenc
phylogenet
infer
pairwis
align
sequenc
code
sequenc
genbank
access
use
program
needl
emboss
rice
et
al
implement
needlemanwunsch
align
use
raxml
stamataki
infer
phylogeni
align
use
gtrcat
codonsubstitut
model
visual
tree
use
r
packag
ggtree
yu
et
al
identifi
pairedend
read
span
n
variabl
site
interest
within
singl
gene
determin
base
present
variabl
site
summar
inform
ndigit
binari
haplotyp
digit
repres
one
variabl
site
repres
ancestr
base
repres
deriv
base
discard
read
span
site
interest
contain
genotyp
common
deriv
base
estim
rate
pcr
recombin
describ
figur
supplement
figur
supplement
figur
supplement
show
number
pairedend
read
use
infer
haplotyp
figur
identifi
site
global
variat
influenza
download
sequenc
global
initi
share
influenza
data
gisaid
epiflu
databas
bogner
et
al
correspond
fulllength
influenza
code
region
human
influenza
isol
collect
januari
decemb
acknowledg
tabl
provid
supplementari
file
pairwis
align
sequenc
code
sequenc
genbank
access
use
program
needl
emboss
rice
et
al
implement
needlemanwunsch
align
calcul
aminoacid
distanc
sequenc
refer
exclud
outlier
whose
distanc
deviat
significantli
sequenc
origin
year
sinc
sequenc
may
misannot
talli
amino
acid
present
codon
posit
year
discard
sequenc
contain
indel
identifi
site
multipl
amino
acid
present
frequenc
least
within
singl
year
consensu
base
chang
year
year
sought
test
probabl
parallel
emerg
mutat
across
multipl
patient
studi
due
chanc
began
simpl
null
model
site
equal
like
mutat
drew
site
gene
random
without
replac
match
number
mutat
observ
patient
calcul
number
uniqu
site
mutat
among
four
patient
simul
data
set
compar
distribut
number
uniqu
site
observ
sequenc
data
fewer
uniqu
site
mutat
indic
parallel
figur
supplement
null
model
overli
simplist
sinc
site
protein
experi
evolutionari
constraint
estim
constraint
limit
number
site
consid
mutabl
site
show
least
two
instanc
nonsynonym
mutat
global
popul
see
analysi
global
variat
figur
supplement
pvalu
given
main
text
calcul
conserv
null
model
also
perform
permut
test
rang
possibl
proport
mutabl
site
calcul
fraction
simul
match
exceed
amount
parallel
observ
data
figur
supplement
use
similar
approach
test
whether
overlap
mutat
observ
within
patient
studi
global
flu
popul
like
due
chanc
drew
two
independ
set
site
gene
random
without
replac
match
total
number
uniqu
variabl
site
within
patient
number
variabl
site
observ
global
popul
calcul
overlap
two
set
site
use
approach
calcul
overlap
simpl
null
model
site
gene
equal
like
mutat
constrain
null
model
mutabl
site
one
show
nonsynonym
mutat
across
rang
possibl
constraint
figur
supplement
fastq
file
avail
sra
bioproject
comput
code
perform
analysi
avail
http
githubcomksxueparallelevolut
copi
archiv
http
githubcomelifesciencespublicationsparallelevolut
supplementari
file
xue
